Vanessa A. Davis

Vanessa Davis protects the rights of individual shareholders and institutional investors by litigating complex securities fraud class actions, in addition to her work advocating for state and local governments that seek to advance public health and safety interests.

Vanessa’s practice includes representing Twitter shareholders in litigation that alleged the social media giant misrepresented its daily user growth in 2015 in order to inflate its stock price. The suit resulted in an $809.5 million proposed settlement in 2021 days before trial.

Vanessa has additional experience in securities cases including:

•Forsta AP-Fonden et al v. St. Jude Medical Inc et al ($39.25 million settlement in 2016*)
•Hatamian v. Advanced Micro Devices, Inc. ($29.5 million settlement in 2017*)
•KBC Asset Mgmt. v. 3D Systems Corp. ($50 million settlement in 2018*)
•In re CenturyLink Sales Practices & Securities Litigation ($55 million settlement in 2021*)

Vanessa’s work for state and local municipalities includes representing the City of Chicago in litigation alleging e-cigarette maker JUUL misled the public on the safety of its products while marketing to children. She is a part of Motley Rice’s team of attorneys who represent dozens of governmental entities, including states, cities, towns, counties and townships in litigation against several pharmaceutical drug manufacturers and distributors for the alleged deceptive marketing of highly addictive opioids.

Prior to her work with Motley Rice, Vanessa represented clients in family court and clerked for an estate planning firm in Charleston, S.C. Vanessa also worked as a paralegal for a personal injury firm while completing her legal studies.

*Please remember that every case is different. Any result we achieve for one client in one matter does not necessarily indicate similar results can be obtained for other clients.

Blog Posts

September 29, 2022

Children say Instagram worsens their mental health Causes, Not Just Cases

by: Previn Warren

July 26, 2022

Nearly $4.25 billion Teva settlement a sign opioid litigation strategy is working to abate the crisis, help communities recover Causes, Not Just Cases

by: Joseph F. Rice

February 25, 2022

Significant opioid relief finally on the way Causes, Not Just Cases

by: Joseph F. Rice

News

May 15, 2026

Federal Court Approves $110 Million Wells Fargo Shareholder Derivative Settlement

by: Motley Rice

April 28, 2025

The history and legacy of Workers’ Memorial Day

by:
M. Nolan Webb